Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03412890
Recruitment Status : Completed
First Posted : January 29, 2018
Last Update Posted : June 9, 2021
Information provided by (Responsible Party):
Myovant Sciences GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 21, 2020
Actual Study Completion Date : January 13, 2021
Certification/Extension First Submitted : December 2, 2020